Gold nanoparticles from magnetite for the detection of amyloid proteins in neurodegenerative diseases

Journal Title: One Health & Risk Management - Year 2022, Vol 3, Issue 1

Abstract

Introduction. Currently, neurodegenerative diseases (ND) are the fourth leading cause of death worldwide that pose a great challenge in the development of tools for early diagnosis. Thus, advances in science seek sensitive and selective detection systems and this manuscript will highlight the importance of nanotechnology. Material and methods. A literature review was conducted on the representative findings of NPs technologies in neurodegenerative diseases. Articles written in both English and Spanish were included. References between 2015-2021 were also taken into account. Results. One of the most representative techniques, AuNP was specifically implemented, together with a magnetic center composed of magnetite, which has as a specific ligand with a C-terminal cysteine domain present in the B-amyloid protein, which adhere directly to the surface of the NPs, characterizing the anomalous protein. Subsequently, by means of nanosensors capable of detecting and measuring different concentrations, these pathologies are identified at an early stage. Conclusions. Today, along with the advent of biotechnology, it has been possible to design techniques with NPs that allow the identification of specific mutations and provide diagnosis in individuals. In the investigative models of AuNP, it is possible to infer that the capabilities that make them representative focus on their magnetism and biofunctionality, by specifically binding to amyloid peptides and other ligands present in the protein, which are the major components of amyloid plaques used in these studies.

Authors and Affiliations

Alejandro ORTIZ, Zeyris HERRERA, Johanna MOSCOSO

Keywords

Related Articles

Hepatitis E: update and perspectives

Introduction. There are approximately 20 million cases of HVE annually worldwide, leading to approximately 3.3 million symptomatic cases of acute hepatitis E. The WHO estimates that HEV caused approximately 44,000 deaths...

Chronic delta hepatitis: from discovery to new treatments

Introduction. Hepatitis delta virus (HDV) is a small, defective RNA virus that is related more to plant viroids than to other human pathogens. Material and methods. Nearly 50 research articles from various sources were...

Evaluation of the compliance of people with the containment measures and wearing-mask behaviours in different stages of COVID-19 pandemic: An observational study from Turkey

Introduction. Protection measurements should be paid attention so that the regions affected to a great extent gain time for medical care and medical facilities can cope with increasing intensive care cases. The purpose o...

Peculiarities of extraction of β-lactoglobuline in protein mineral concentrates at electroactivation of whey

Introduction. Whey is a by-product and an excellent source of proteins that is rather aggressive due to a large amount of organic substances it contains. The electro-activation of whey applied in the experiments is a was...

Concerns regarding the effects of the COVID19 pandemic on children health

Introduction. The unexpected situations (lockdown, online school, social distancing) introduced from March 2020 to stop the spread of COVID-19 in most countries worldwide, have affected every citizen. Currently, after mo...

Download PDF file
  • EP ID EP698659
  • DOI 10.38045/ohrm.2022.1.02
  • Views 16
  • Downloads 0

How To Cite

Alejandro ORTIZ, Zeyris HERRERA, Johanna MOSCOSO (2022). Gold nanoparticles from magnetite for the detection of amyloid proteins in neurodegenerative diseases. One Health & Risk Management, 3(1), -. https://europub.co.uk/articles/-A-698659